OrbiMed Advisors
http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.
View Older Stories View More Recent Stories
-
ViewRay (VRAY) Raises $26.1 Million in Private Placement of Common Stock and Warrants
-
ViewRay Raises $26.1 Million in Private Placement
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 3 Nabriva Therapeutics AG For: Dec 30 Filed by: ORBIMED ADVISORS LLC
-
Sonendo® Closes $35 Million Equity Financing Round
-
Treato Appoints Healthcare Industry Veteran Allen Kamer to its Board of Directors
-
Form SC 13G/A SUNOVION CNS DEVELOPMENT Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A RESPONSE BIOMEDICAL CORP Filed by: ORBIMED ADVISORS LLC
-
Response Biomedical Corp. Completes Going-Private Transaction
-
Inspire Medical Systems Completes 1,000th Implant, Names Marilyn Carlson Nelson to the Board, and Completes Series F Financing
-
Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
-
Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
-
FACIT Start-up Turnstone Biologics Closes USD $41M Financing
-
Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
-
Unilife Corp. (UNIS) Issues Accelerated Convertible Note to Amgen
-
PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
-
Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
-
Form 4 Roka BioScience, Inc. For: Sep 21 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
-
Response Biomedical Corp. Receives Shareholder Approval of Going-Private Transaction
-
Form SC 13G/A Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
-
Inspire Medical Systems Reaches over 1,000 Implants for the Treatment of Obstructive Sleep Apnea
-
ViewRay, Inc. (VRAY) Enters $13.75M Common Stock Private Placement
-
ViewRay Announces $13.75 Million Private Placement
-
Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
-
Form SC 13D SteadyMed Ltd. Filed by: ORBIMED ADVISORS LLC
-
Form 3 SteadyMed Ltd. For: Aug 04 Filed by: ORBIMED ADVISORS LLC
-
Form 4 Loxo Oncology, Inc. For: Aug 10 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
-
ORIC Pharmaceuticals Appoints Ashraf Hanna, PhD, MD, as Chief Executive Officer, and Darcy Mootz, PhD, as Chief Business Officer
-
Lion Biotechnologies Announces Second Quarter 2016 Financial Results
-
Cleave Biosciences Raises $37 Million Series B Financing
-
Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 4 GLAUKOS Corp For: Aug 03 Filed by: ORBIMED ADVISORS LLC
-
Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update
-
Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
-
Avitide, Inc., to Expand Affinity Separation Discovery and Manufacturing Operations
-
Form 4 Relypsa Inc For: Jul 22 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
-
Form 4 Audentes Therapeutics, For: Jul 25 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D SELECTA BIOSCIENCES INC Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
-
Form 4 SELECTA BIOSCIENCES INC For: Jun 27 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
-
Positive Patient Outcomes Data on Inspire Therapy Highlighted at SLEEP 2016
-
Form 4 RESPONSE BIOMEDICAL CORP For: Jun 16 Filed by: OrbiMed Advisors Ltd

